CEBPA and acute myeloid leukemia: Thus, a lack of fully functional RUNX1 or CEBPA proteins in AML patients with a corresponding mutation could prevent the interaction of TET2 with the regions around their TFBS, leading to methylation of regulatory regions and suppression of several genes’ expressions.